except as required by law. Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, TransCon, and SKYTROFA ...

Gland Pharma received a US FDA approval for Phytonadione Injectable Emulsion. The product is indicated in coagulation disorders caused by Vitamin K deficiency. Ami Organics approved enhancement in ...

LTR Pharma Limited (AU:LTP) has released an update. Pick the best stocks and maximize your portfolio: Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify ...

Don't Miss our Black Friday Offers: Tonix Pharma ( (TNXP)) just unveiled an announcement. Tonix Pharmaceuticals is strategically strengthening its leadership team by appointing new executives as ...

On Friday, November 29th, the pharmaceutical sector showed strong performance with Sun Pharma closing up by 3% and Cipla rising nearly ... drops iconic four rings logo in newly launched electric ...

Pharma advertising spending on YouTube in the United States in 1st quarter 2022 and 1st quarter 2023 (in million U.S. dollars) Characteristic Advertising spending in million U.S. dollars ...

Lupin Ltd , Abbott India Ltd, Glenmark Pharmaceuticals, Dr Reddy's Laboratories Ltd CIPLA Ltd and Zydus Lifesciences outperformed IPM delivering 6-8% growth in October suggested Centrum Data. Alkem ...

UBS has recently reduced Royalty Pharma plc (RPRX) stock to Neutral rating, as announced on June 3, 2024, according to Finviz. Earlier, on June 14, 2022, UBS had resumed the stock to Buy, setting a ...

The change was primarily tied the impact of currency fluctuations. For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted ...

On the India business front, in particular, Cipla is working to not only enhance its prescription base but also strengthen its trade generics and consumer healthcare businesses. MUMBAI - After ...